´ëÇѺÎÀÎÁ¾¾çÇÐȸ The 6th Biennial Meeting of Asian Society ofGynecologic Oncology (ASGO 2019), 25th Annual Symposium of KSGO 2019 : 2019-10-11±³À°ÀÏÀÚ : 2019-10-11
±³À°Àå¼Ò : ¼Ûµµ ÄÁº¥½Ã¾Æ ½Å°ü ±×·£µåº¼·ë ¹× ¼ÒȸÀǽÇ
±³À°ÁÖÁ¦ :
The 6th Biennial Meeting of Asian Society ofGynecologic Oncology (ASGO 2019), 25th Annual Symposium of KSGO 2019ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
´ã´çÀÚ : ±è¹ÎÇý
¿¬¶ôó : 02-3452-1855
À̸ÞÀÏ :
asgo2019@aim-korea.com ±³À°Á¾·ù : »êºÎÀΰú
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
ÀÎõ±¤¿ª½Ã±³À°½Ã°£ : 15 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 500,000¿ø
ºñ°í (ÇöÀåµî·Ïºñ ±âÁØ) ºÎÀÎÁ¾¾ç°ú/ Ÿ°ú Àü¹®ÀÇ/ Á¦¾à»ç ´ã´çÁ÷¿ø: 500,000¿ø ÀüÀÓÀÇ/¼ö·ÃÀÇ: 400,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-11 GBR A 08:30~08:45 Validating new (2018) FIGO staging of cervix cancer Kailash Narayan(Peter MacCallum Cancer Centre OBGYN, University of Melbourne)
±³À°½Ã°£ 10-11 GBR A 08:45~09:00 Pathologic perspectives in revised FIGO Hyojin Kim(Seoul National University Bundang Hospital)
±³À°½Ã°£ 10-11 GBR A 09:00~09:15 Status of less-radical surgery in Japan Takahide Arimoto(Toranomon Hospital)
±³À°½Ã°£ 10-11 GBR A 09:15~09:30 Predictive models for metastasis and recurrence after radical hysterectomy in patients with early-stage cervical cancer Kittipat Charoenkwan(Faculty of Medicine, Chiang Mai University)
±³À°½Ã°£ 10-11 GBR A 09:30~09:45 Surgical staging in advanced stage Chel Hun Choi(Samsung Medical Center)
±³À°½Ã°£ 10-11 GBR B 08:30~08:50 How to avoid futile LND in early stage endometrial cancer Sokbom Kang(National Cancer Center)
±³À°½Ã°£ 10-11 GBR B 08:50~09:10 LND issues in endometrial cancer Hidemichi Watari(Hokkaido University Graduate School of Medicine and Faculty of Medicine)
±³À°½Ã°£ 10-11 GBR B 09:10~09:30 Molecular classification of endometrial cancer Kidong Kim(Seoul National University Bundang Hospital)
±³À°½Ã°£ 10-11 GBR B 09:30~09:50 Preservation of ovary in the management of endometrial carcinoma Kun Song(Qilu Hospital of Shandong University)
±³À°½Ã°£ 10-11 206-207 08:30~08:45 Pre and postoperative management in gynecologic cancer surgery with planned bowel resection Jung Myun Kwak(Korea University Anam Hospital)
±³À°½Ã°£ 10-11 206-207 08:45~09:00 Pain management and anesthetic issue Jin-Tae Kim(Seoul National University)
±³À°½Ã°£ 10-11 206-207 09:10~09:25 Ovarian clear cell carcinoma: molecular characterization of sensitivity to platinum-based chemotherapy Masataka Takenaka(The Jikei University School of Medicine)
±³À°½Ã°£ 10-11 206-207 09:25~09:40 Molecular profiling of ovarian clear cell carcinomas: implications for therapy Ruby Huang(National Taiwan University)
±³À°½Ã°£ 10-11 206-207 09:40~09:55 Genomics to immunotherapy of ovarian clear cell carcinoma Katsutoshi Oda(The University of Tokyo)
±³À°½Ã°£ 10-11 GBR A, GBR B 10:20~10:35 Selection criteria and principles for 2nd debulking surgery: Expert point of view Dennis Chi(Memorial Sloan Kettering Cancer Center)
±³À°½Ã°£ 10-11 GBR A, GBR B 10:35~10:50 Surgery for recurrent ovarian cancer. Evidence from DESKTOP series and others Andreas du Bois(Kliniken Essen-Mitte (KEM))
±³À°½Ã°£ 10-11 GBR A, GBR B 10:50~11:05 GOG 213 surgical part Robert Coleman(University of Texas MD Anderson Cancer Center)
±³À°½Ã°£ 10-11 GBR A, GBR B 11:15~11:30 Real Problems of Laparoscopic Radical Hysterectomy Joo-Hyun Nam(University of Ulsan, Asan Medical Center)
±³À°½Ã°£ 10-11 GBR A, GBR B 11:30~11:45 Asian viewpoint Mikio Mikami(Tokai University School of Medicine)
±³À°½Ã°£ 10-11 GBR A, GBR B 11:45~12:00 American and the other world viewpoint Mario Leitao(Memorial Sloan Kettering Cancer Center)
±³À°½Ã°£ 10-11 GBR A, GBR B 12:20~12:40 Role of avastin in ovarian cancer & evolution as backbone of novel combination Mansoor R Mirza(Rigshospitalet Copenhagen University Hospital)
±³À°½Ã°£ 10-11 GBR A, GBR B 13:10~13:30 PARP inhibition in ovarian cancer: Is it time for a paradigm shift? Richard Penson(Massachusetts General Hospital)
±³À°½Ã°£ 10-11 GBR A, GBR B 13:30~13:50 Prevalence of BRCA mutation and real world experience of PAPRi Byoung-Gie Kim(Sungkyunkwan University)
±³À°½Ã°£ 10-11 GBR A, GBR B 13:50~14:10 Biomarkers for immunotherapy usage in gynecologic cancer Wei Zhou(Merck Research Labotories)
±³À°½Ã°£ 10-11 GBR A, GBR B 14:10~14:30 Novel and emerging agents under development for gynecologic cancers David Tan(National University Cancer Institute Singapore)
±³À°½Ã°£ 10-11 GBR A 15:00~15:20 Establishing BRCA consortium in Asia Sung-Won Kim(Daerim St. Mary¡¯s Hospital)
±³À°½Ã°£ 10-11 GBR A 15:20~15:40 Strategies of genetic test and counseling in Asia Masayuki Sekine(Niigata University)
±³À°½Ã°£ 10-11 GBR A 15:40~16:00 Clinical impact of hereditary predisposition in gynecologic cancer Myong-Cheol Lim(National Cancer Center)
±³À°½Ã°£ 10-11 GBR A 16:00~16:20 A need of Asian guidelines for the management of BRCA carrier Arb-aroon Lertkhachonsuk(Faculty of Medicine Ramathibodi Hospital, Mahidol University)
±³À°½Ã°£ 10-11 GBR B 15:00~15:15 Sentinel lymph node biopsy in cervical and vulvar cancer Mario Leitao(Memorial Sloan Kettering Cancer Center)
±³À°½Ã°£ 10-11 GBR B 15:15~15:30 Robotic approach for high-risk endometrial cancer Jiheum Paek(Ajou University School of Medicine)
±³À°½Ã°£ 10-11 GBR B 15:30~15:45 Sentinel lymph node staging experience in Thailand Nuttavut Kantathavorn(HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy)
±³À°½Ã°£ 10-11 GBR B 15:45~16:00 Two-step sentinel lymph node mapping strategy in endometrial cancer Sang-Wun Kim(Yonsei Cancer Center)
±³À°½Ã°£ 10-11 GBR B 16:00~16:15 Current role of minimally invasive surgery for ovarian cancer Jeong-Yeol Park(University of Ulsan College of Medicine Asan Medical Center)
±³À°½Ã°£ 10-11 206-207 15:00~15:10 Antitumor Effect of FGFR Inhibitor AZD4547 in Ovarian Cancer Cells So-Jin Shin(Keimyung University Dongsan Medical Center)
±³À°½Ã°£ 10-11 206-207 15:10~15:20 Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo Keqi Song(Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University)
±³À°½Ã°£ 10-11 206-207 15:20~15:30 YAP silencing using dobutamine-PLGA nanoparticle as a new therapeutic strategy for ovarian cancer Ju-Won Roh(Dongguk University)
±³À°½Ã°£ 10-11 206-207 15:30~15:40 Tyrosine kinase receptor TIE-1 mediates cell growth by regulating PI3K/Akt signaling pathway in PI3K-high-expressing ovarian cancer. Xuewei Zhang(Tohoku University Graduate School of Medicine)
±³À°½Ã°£ 10-11 206-207 15:40~15:50 First-in-human trial of the oral ataxia telangiectasia and Rad3-related (ATR) inhibitor BAY 1895344 in patients (pts) with advanced solid tumors. David Tan(National University Cancer Institute Singapore)
±³À°½Ã°£ 10-11 206-207 15:50~16:00 The Roles of Androgen Receptor in Chemosensitivity in Serous Ovarian Cancer Hung-Chun Fu(Kaohsiung Chang Gung Memorial Hospital)
±³À°½Ã°£ 10-11 206-207 16:00~16:10 Cancer Stem Cell (CD133, CD44 and ALDH1A1) Markers As Prognostic Factors on Epithelial Ovarian Cancer Nugraha Pelupessy(University of Hasanuddin)
±³À°½Ã°£ 10-11 206-207 16:10~16:20 Low expression of gamma-glutamyl transpeptidase 1 is an independent poor prognostic factor associated with up-regulation of immune suppressive genes and EMT-related genes in ovarian clear cell carcinoma Hiroshi Asano(Hokkaido University)
±³À°½Ã°£ 10-11 206-207 16:20~16:30 The Role Of Akt2, and CA-125 Serum Levels As Predictors For Cytoreduction In Epithelial Ovarian Cancer Surgery Yudi Mulyana Hidayat(Padjadjaran University / Dr. Hasan Sadikin General Hospital)
±³À°½Ã°£ 10-11 GBR A 16:50~17:00 Case presentation: cervix cancer U Chul Ju(Chonnam National University Hwasun Hospital)
±³À°½Ã°£ 10-11 GBR A 17:00~17:15 Comments on of the cervical cancer management Hung-Cheng Lai(Shuang Ho Hospital, Taipei Medical University)
±³À°½Ã°£ 10-11 GBR A 17:20~17:30 Case presentation: endometrial cancer Yiqin Wang(Peking University People)
±³À°½Ã°£ 10-11 GBR A 17:30~17:45 Comments on various aspects of the case management Janice Kwon(University of British Columbia)
±³À°½Ã°£ 10-11 GBR A 17:50~18:00 Case presentation: epithelial ovarian cancer Won-Kyo Shin(National cancer center, Korea)
±³À°½Ã°£ 10-11 GBR A 18:00~18:15 Comments on various aspects of the case management Masaki Mandai(Kyoto University Graduate School of Medicine)
±³À°½Ã°£ 10-11 GBR B 16:50~17:10 Elimination of cervical cancer: Global overview and prospects for Asia Neerja Bhatla(All India Institute of Medical Sciences)
±³À°½Ã°£ 10-11 GBR B 17:10~17:30 VIA with Picture as One Option Strategy in Increasing the Cervical Cancer Screening Coverage in Low Resource Setting area Dwiana Ocviyanti(Universitas Indonesia AOGIN)
±³À°½Ã°£ 10-11 GBR B 17:30~17:50 HPV test as a primary cervical cancer screening Warner Huh(University of Alabama at Birmingham)
±³À°½Ã°£ 10-11 GBR B 17:50~18:10 Cost-effectiveness of primary HPV test and triage test in cervical cancer screening Wichai Termrungruanglert(Chulalongkorn University)
±³À°½Ã°£ 10-11 206-207 16:50~17:00 Risk factors for lymph node metastasis in FIGO stage I-IIIC endometrioid carcinoma according to lymphovascular space invasion Joo-Hyuk Son(Ajou University Hospital)
±³À°½Ã°£ 10-11 206-207 17:00~17:10 Development of novel diagnosis method of uterine cancer using lymph node metastasis predictive biomarker for more personalized lymphadenectomy. Emiko Yoshida(Juntendo University)
±³À°½Ã°£ 10-11 206-207 17:10~17:20 Comparison of ROMA algorithm and CA 125 as tools for discriminate benign ovarian tumor and early stage ovarian cancer according to imaging tumor subtypes that connected to postoperative histopathologic findings Youngjae Lee(Asan Medical Center)
±³À°½Ã°£ 10-11 206-207 17:20~17:30 Inadvertent ovarian malignancy following operative laparoscopy of adnexal masses: University Malaya Medical Centre experience. Muhammad Asyaraf Azizan(University Malaya Medical Center)
±³À°½Ã°£ 10-11 206-207 17:30~17:40 Analysis of factors influencing the recurrence and fertility outcomes of ovarian borderline tumors Zhengmao Zhang(Fourth Hospital of Hebei Medical University)
±³À°½Ã°£ 10-11 206-207 17:40~17:50 The effect of pelvic and para-aortic lymphadenectomy for clinically-apparent stage I endometrioid epithelial ovarian carcinoma Masato Yoshihara(Nagoya University)
±³À°½Ã°£ 10-11 206-207 17:50~18:00 Survival impact of complete resection of supradiaphragmatic lymph nodes in advanced ovarian cancer for optimal cytoreduction Soo Jin Park(Seoul National University Hospital)
±³À°½Ã°£ 10-11 206-207 18:00~18:10 Oncologic outcomes after secondary surgery in recurrent clear-cell carcinoma of the ovary Shohei Iyoshi(Nagoya University)
±³À°½Ã°£ 10-11 206-207 18:10~18:20 Knowledge, Attitude and Practices of Gynecologists in a Tertiary Hospital on Preoperative Bowel Preparation Gladdy Maura Facun(Philippine General Hospital)